| Literature DB >> 25492409 |
Tiina Lipiäinen1, Marikki Peltoniemi, Sanjay Sarkhel, Teijo Yrjönen, Heikki Vuorela, Arto Urtti, Anne Juppo.
Abstract
Cytokines are messenger proteins that regulate the proliferation and differentiation of cells and control immune responses. Interferons, interleukins, and growth factors have applications in cancer, autoimmune, and viral disease treatment. The cytokines are susceptible to chemical and physical instability. This article reviews the structure and stability issues of clinically used cytokines, as well as formulation strategies for improved stability. Some general aspects for identifying most probable stability concerns, selecting excipients, and developing stable cytokine formulations are presented. The vast group of cytokines offers possibilities for new biopharmaceuticals. The formulation approaches of the current cytokine products could facilitate development of new biopharmaceuticals.Entities:
Keywords: biopharmaceuticals characterization; biosimilar; excipients; injectables; lyophilization; oxidation; protein aggregation; protein formulation; protein structure; solid state
Mesh:
Substances:
Year: 2014 PMID: 25492409 DOI: 10.1002/jps.24243
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.534